JTT-654

JTT-654 · Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JTT-654, covering 2013-02-04 to 2013-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients [Phase 2]